Automating Infusion Therapy Prior Authorization for Enhanced Patient Access

Klivira's platform automates Infusion Therapy prior authorization, ensuring timely approvals for critical specialty medications delivered in-office, outpatient, or at home.

Managing prior authorizations for infusion therapy presents unique challenges, from complex specialty drug protocols to stringent site-of-service review requirements. Revenue cycle directors and prior authorization coordinators face increasing administrative burden and potential delays in patient care due to manual processes and varied payer rules. Klivira addresses these complexities by streamlining the entire PA workflow.

Navigating the Complexities of Infusion Therapy PA

Infusion therapy often involves high-cost specialty drugs, requiring precise documentation and adherence to constantly evolving payer policies. A significant dimension is site-of-service review, where payers scrutinize the medical necessity for home infusion versus an outpatient hospital department (HOPD) or physician's office. This necessitates robust systems to manage diverse requirements and ensure compliance.

Key Challenges in Infusion Therapy Prior Authorization Workflows

Manual collection and submission of extensive clinical documentation for specialty drugs.
Varied and frequently updated payer-specific rules for infusion services and site-of-service.
Delays in obtaining PA, impacting patient treatment schedules and revenue cycles.
High rates of denials or appeals due to incomplete submissions or coding errors.
Lack of real-time visibility into PA status across multiple payer portals.

Klivira's Solution for Infusion Therapy PA Automation

Klivira integrates directly with your EMR and payer portals to automate the entire prior authorization lifecycle for infusion therapy. Our platform leverages AI and machine learning to extract clinical data, generate comprehensive documentation, and facilitate accurate X12 278 transactions. This dramatically reduces manual effort and accelerates approval times for critical infusion services.

Optimizing Site-of-Service Review and Specialty Drug Approvals

Automated identification of site-of-service requirements based on payer rules and clinical data.
Intelligent routing of PA requests to appropriate payer channels, including Da Vinci PAS integration.
Proactive alerts for missing documentation specific to specialty drug protocols.
Real-time tracking of PA status, minimizing delays for home infusion and outpatient services.
Reduction in administrative overhead for PA coordinators managing complex infusion cases.

Seamless Integration with Your Healthcare Ecosystem

Our platform is designed for interoperability, integrating with leading EMRs via SMART on FHIR and other standard APIs. This ensures a cohesive workflow, minimizing data entry and maximizing data accuracy across your clinical and administrative systems. Klivira acts as an extension of your existing infrastructure, enhancing efficiency without disruption.

Frequently asked questions

How does Klivira manage site-of-service review requirements for infusion therapy?

Klivira's platform intelligently analyzes payer-specific policies and clinical documentation to identify appropriate site-of-service requirements (e.g., home, HOPD, office). It then guides the submission process to ensure all necessary data points supporting the chosen site are included, reducing the likelihood of denials related to site-of-service review.

Can Klivira integrate with our EMR for infusion therapy orders and documentation?

Yes, Klivira is built for seamless integration with major EMR systems using industry standards like SMART on FHIR. This allows for automated extraction of patient demographics, clinical notes, and order details directly from your EMR to populate prior authorization requests for infusion therapy, minimizing manual data entry and improving accuracy.

What role does Klivira play in submitting X12 278 transactions for infusion services?

Klivira automates the generation and submission of X12 278 transactions, the standard electronic format for prior authorization requests, directly to payers. For infusion services, this ensures a compliant and efficient digital exchange of authorization requests, accelerating the entire approval process compared to fax or phone-based methods.

How does Klivira handle updates to payer-specific infusion therapy policies?

Klivira continuously monitors and updates its rules engine with the latest payer-specific policies and clinical criteria for infusion therapy. This proactive approach ensures that your prior authorization submissions remain compliant with current requirements, reducing the risk of denials due to outdated information.

Does Klivira support prior authorization for both outpatient and home infusion services?

Yes, Klivira supports the full spectrum of infusion therapy settings, including in-office, outpatient hospital departments (HOPD), and home infusion. The platform is designed to adapt to the unique documentation and submission requirements associated with each site of service, ensuring comprehensive coverage for all your infusion programs.